Generation and identification of natural monoclonal antibodies against low-density lipoprotein

Hybridoma

Volumn 27, Issue 1, 2008, Pages 54-58

  Feng, Xuyang ^a   Xu, Ruifen ^b   Gao, Yan ^c   He, Zheng ^a   Li, Chengxiang ^a   Wang, Haichang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; CELL SECRETION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYBRIDOMA; IMMUNOPRECIPITATION; LIPID METABOLISM; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CHOLESTEROL, DIETARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN M; LIPOPROTEINS, LDL; MICE; MICE, INBRED BALB C;

MUS;

EID: 39749126895     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2007.0535     Document Type: Article

References (11)

1. Baumgarth NJ, Tung W, and Herzenberg LA: Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005;26:347-362.
2. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, and Wick G: Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 2004;22:361-403.
3. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, and Witztum JL: Innate and acquired immunity in atherogenesis. Nat Med 2002;8(11):1218-1226.
4. Glass CK, and Witztum JL: Atherogenesis. The road ahead. Cell 2001;104:503-516.
5. Hansson GK, Libby P, Schonbeck U, and Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherogenesis. Circ Res 2002;91:281-291.
6. Steinberg D: Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy. Part III: mechanistically defining the role of hyperlipidemia. J Lipid Res 2005;46(10):2037-2051.
7. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Poclinski W, Witztam JL: Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 1999;103(1):117-128.
8. Belcher JD, Eqan JO, Bridgman G, Baker R, and Flack JM: A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein ubfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serum. J Lipid Res 1991;32(2):359-370.
9. Harlow DL (Ed.). Using Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Harbor, NY, 1999.
10. Haury M, Sundblad A, and Grandien A: The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 1997;27(6):1557-1563.
11. Feng XY, Wang HC, Fu M, and Xing Y. The detection and analysis of natural antibodies against cholesterol. Chinese Heart J 2007;19(2):173-175.